NFAT inhibitor, Cell Permeable

A cell-permeable compound that inhibits calcineurin-mediated NFAT activation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R0937

CAS No:592517-80-1

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C147H259N67O36S
M.W/Mr.
3573.15
Sequence
RRRRRRRRRRRGGGMAGPHPVIVITGPHEE
Appearance
White lyophilised solid
Purity
>95%
Activity
Inhibitor

NFAT inhibitor, Cell Permeable, is a specialized small molecule compound designed to modulate the activity of the nuclear factor of activated T-cells (NFAT) family of transcription factors. As a cell-permeable agent, it can efficiently traverse cellular membranes, enabling direct intracellular modulation of NFAT-dependent signaling pathways. NFAT proteins play a pivotal role in regulating gene expression in immune cells, particularly in T lymphocytes, and are central to numerous cellular processes including activation, differentiation, and cytokine production. The ability to selectively inhibit NFAT function provides researchers with a precise tool for dissecting the molecular mechanisms underlying immune responses, cell signaling, and gene regulation.

Immunology research: In the context of immunological studies, NFAT inhibitors are invaluable for unraveling the intricacies of T-cell activation and function. By blocking NFAT translocation and transcriptional activity, these compounds allow scientists to investigate the downstream effects on cytokine gene expression, T-cell proliferation, and differentiation. Such studies are essential for understanding the molecular basis of immune tolerance, autoimmunity, and the cellular response to antigenic stimulation.

Signal transduction studies: The cell-permeable nature of the inhibitor enables efficient modulation of intracellular signaling cascades involving calcineurin and NFAT. Researchers can employ the compound to dissect the contribution of NFAT to calcium-dependent signaling pathways across various cell types. This facilitates exploration of cross-talk with other transcription factors, such as AP-1 or NF-κB, and helps elucidate the broader regulatory networks governing cellular activation and gene expression.

Gene regulation analysis: NFAT family members are key regulators of inducible gene expression in multiple biological contexts. Application of a selective NFAT inhibitor permits detailed examination of target gene networks under both physiological and experimental conditions. Scientists can employ it to distinguish between NFAT-dependent and -independent transcriptional events, thereby clarifying the role of specific NFAT isoforms in the control of immune effector functions or developmental processes.

Cellular differentiation assays: The compound is frequently utilized in studies probing the influence of NFAT signaling on cell fate decisions. In hematopoietic and non-hematopoietic lineages, selective inhibition of NFAT can reveal its involvement in differentiation pathways, such as those leading to effector T cells, regulatory T cells, or osteoclasts. Such experiments are instrumental in mapping lineage specification and understanding the molecular checkpoints that govern cellular identity.

Drug discovery and screening: NFAT inhibitors serve as important tools in high-throughput screening platforms aimed at identifying novel modulators of immune signaling. By providing a reference inhibitor with well-characterized activity and cell permeability, researchers can benchmark the efficacy of new compounds targeting the calcineurin-NFAT axis. This accelerates the development of research probes and potential leads for immune modulation, facilitating the advancement of basic and translational studies in immunology and cell biology.

Solubility
-20 °C
InChI
InChI=1S/C147H259N67O36S/c1-12-75(7)109(133(246)208-108(74(5)6)132(245)210-110(76(8)13-2)134(247)211-111(78(10)215)130(243)188-70-104(220)212-58-25-39-97(212)127(240)205-95(62-79-64-171-71-189-79)126(239)203-92(42-44-105(221)222)125(238)204-94(136(249)250)43-45-106(223)224)209-131(244)107(73(3)4)207-129(242)99-41-27-60-214(99)135(248)96(63-80-65-172-72-190-80)206-128(241)98-40-26-59-213(98)103(219)69-187-112(225)77(9)191-115(228)93(46-61-251-11)192-102(218)68-185-100(216)66-184-101(217)67-186-114(227)82(29-15-48-174-138(151)152)194-117(230)84(31-17-50-176-140(155)156)196-119(232)86(33-19-52-178-142(159)160)198-121(234)88(35-21-54-180-144(163)164)200-123(236)90(37-23-56-182-146(167)168)202-124(237)91(38-24-57-183-147(169)170)201-122(235)89(36-22-55-181-145(165)166)199-120(233)87(34-20-53-179-143(161)162)197-118(231)85(32-18-51-177-141(157)158)195-116(229)83(30-16-49-175-139(153)154)193-113(226)81(148)28-14-47-173-137(149)150/h64-65,71-78,81-99,107-111,215H,12-63,66-70,148H2,1-11H3,(H,171,189)(H,172,190)(H,184,217)(H,185,216)(H,186,227)(H,187,225)(H,188,243)(H,191,228)(H,192,218)(H,193,226)(H,194,230)(H,195,229)(H,196,232)(H,197,231)(H,198,234)(H,199,233)(H,200,236)(H,201,235)(H,202,237)(H,203,239)(H,204,238)(H,205,240)(H,206,241)(H,207,242)(H,208,246)(H,209,244)(H,210,245)(H,211,247)(H,221,222)(H,223,224)(H,249,250)(H4,149,150,173)(H4,151,152,174)(H4,153,154,175)(H4,155,156,176)(H4,157,158,177)(H4,159,160,178)(H4,161,162,179)(H4,163,164,180)(H4,165,166,181)(H4,167,168,182)(H4,169,170,183)/t75-,76-,77-,78+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,107-,108-,109-,110-,111-/m0/s1
InChI Key
VNTCWMOQGXMIQP-PIQGMSCVSA-N
Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CNC=N4)NC(=O)[C@@H]5CCCN5C(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide CDMOEpitope Mapping ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisPeptide Synthesis ServicesPeptide Modification ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers